Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes

Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...

Descripción completa

Detalles Bibliográficos
Autor principal: Neumiller, Joshua J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220591/
https://www.ncbi.nlm.nih.gov/pubmed/25646943
http://dx.doi.org/10.2337/diaclin.32.4.170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220591/
https://www.ncbi.nlm.nih.gov/pubmed/25646943
http://dx.doi.org/10.2337/diaclin.32.4.170

Ejemplares similares